Edison Pharmaceuticals is a specialty pharmaceutical company dedicated to developing treatments for children with orphan mitochondrial diseases.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
11/27/12 | $20,000,000 | Series F |
Mitsui Global Investment | undisclosed |